Benjamin Strain

No open positions remaining

Health Technology

Consumer Services

Finance

Profile

Benjamin J.
Strain worked as Associate Portfolio Manager at The Boston Company Asset Management LLC.
Served as Senior Manager-Investor Relations at Biogen, Inc. Held the position of Head-Investor Relations & Communications at Paratek Pharmaceuticals, Inc. from 2018 to 2021.
Worked as Vice President-Investor Relations & Communications at Foghorn Therapeutics, Inc. from 2021 to 2023.
Served as Head-Investor Relations at Incyte Corp.
from 2023 to 2025.
Completed undergraduate studies at Peter T Paul College of Business & Economics.
Earned an MBA from McCallum Graduate School of Business.

Former positions of Benjamin Strain

Companies	Position	End
INCYTE CORPORATION	Investor Relations Contact	01/01/2025
FOGHORN THERAPEUTICS INC.	Investor Relations Contact	01/09/2023
PARATEK PHARMACEUTICALS, INC.	Investor Relations Contact	01/08/2021
The Boston Company Asset Management LLC The Boston Company Asset Management LLC Investment ManagersFinance The Boston Company Asset Management (TBCAM) offers both traditional and alternative equity investment products that encompass a variety of US, non-US and global strategies. The firm provides investment advice for the following types of strategies: US domestic equity, balanced, non-US equity, emerging markets equity and long/short equity. Portfolios generally are composed of individual securities. TBCAM seeks consistent delivery of alpha across a broad range of investment strategies. They are committed to a value-oriented, research-driven and risk-aware investment approach. TBCAM seeks to identify attractive stocks through rigorous quantitative and fundamental analyses blended with analysis of current business momentum and places controls on sector selection and, if applicable, country selection. Short sales and similar strategies are considered part of their overall investment strategy; however, they are not used across the account base in the management of account assets. The firm may use these strategies for certain accounts consistent with the client's guidelines, objectives, and restrictions.	Portfolio Manager-Equities	06/01/2009
BIOGEN INC.	Public Communications Contact	-

See the detail of Benjamin Strain's experience

Training of Benjamin Strain

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Benjamin Strain's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
The Boston Company Asset Management LLC The Boston Company Asset Management LLC Investment ManagersFinance The Boston Company Asset Management (TBCAM) offers both traditional and alternative equity investment products that encompass a variety of US, non-US and global strategies. The firm provides investment advice for the following types of strategies: US domestic equity, balanced, non-US equity, emerging markets equity and long/short equity. Portfolios generally are composed of individual securities. TBCAM seeks consistent delivery of alpha across a broad range of investment strategies. They are committed to a value-oriented, research-driven and risk-aware investment approach. TBCAM seeks to identify attractive stocks through rigorous quantitative and fundamental analyses blended with analysis of current business momentum and places controls on sector selection and, if applicable, country selection. Short sales and similar strategies are considered part of their overall investment strategy; however, they are not used across the account base in the management of account assets. The firm may use these strategies for certain accounts consistent with the client's guidelines, objectives, and restrictions.	Finance
Incyte Corp. Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics	Health Technology
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Peter T Paul College of Business & Economics Peter T Paul College of Business & Economics Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Paratek Pharmaceuticals, Inc. Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
McCallum Graduate School of Business McCallum Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Foghorn Therapeutics, Inc. Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders	Health Technology